Related references
Note: Only part of the references are listed.ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer
Jianning Sun et al.
JOURNAL OF MOLECULAR HISTOLOGY (2015)
β2-Microglobulin-mediated Signaling as a Target for Cancer Therapy
Takeo Nomura et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
Characterization of β2-microglobulin expression in different types of breast cancer
Kesheng Li et al.
BMC CANCER (2014)
Gastric cancer progression may involve a shift in HLA-E profile from an intact heterodimer to β2-microglobulin-free monomer
Toshiyuki Sasaki et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma
Ana B. del Campo et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
Tsz-Lun Yeung et al.
CANCER RESEARCH (2013)
Activation of complement by monoclonal antibodies that target cell-associated β2-microglobulin: Implications for cancer immunotherapy
Michael J. Pokrass et al.
MOLECULAR IMMUNOLOGY (2013)
HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression
Celine Bossard et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma
Yu-Hsiang Lee et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Comparative analysis of CA 125, ferritin, beta-2 microglobulin, lactic dehydrogenase levels in serum and peritoneal fluid in patients with ovarian neoplasia
Umran Kucukgoz Gulec et al.
MEDICAL ONCOLOGY (2012)
TGF-Beta Induces Serous Borderline Ovarian Tumor Cell Invasion by Activating EMT but Triggers Apoptosis in Low-Grade Serous Ovarian Carcinoma Cells
Jung-Chien Cheng et al.
PLOS ONE (2012)
β2-Microglobulin Induces Epithelial to Mesenchymal Transition and Confers Cancer Lethality and Bone Metastasis in Human Cancer Cells
Sajni Josson et al.
CANCER RESEARCH (2011)
Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells
Miranda P. Ween et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells
Nathan J. Bowen et al.
BMC MEDICAL GENOMICS (2009)
An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules
Huaxia Qin et al.
BMC SYSTEMS BIOLOGY (2009)
Identification of beta2-microglobulin as a potential target for ovarian cancer
Han Shuo Yang et al.
CANCER BIOLOGY & THERAPY (2009)
β2 microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients
J. Shrout et al.
BRITISH JOURNAL OF CANCER (2008)
Immunological profiling of a panel of human ovarian cancer cell lines
TiVany M. Carr et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
β-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer
Mitchell Gross et al.
CLINICAL CANCER RESEARCH (2007)
Role of endocrine and growth factors on the ovarian surface epithelium
Alice S. T. Wong et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2007)
β2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis
Takeo Nomura et al.
CLINICAL CANCER RESEARCH (2006)
Two major Smad pathways in TGF-β superfamily signalling
K Miyazawa et al.
GENES TO CELLS (2002)
Transcriptional control by the TGF-β/Smad signaling system
J Massagué et al.
EMBO JOURNAL (2000)
Mechanisms of disease:: Role of transforming growth factor β in human disease.
GC Blobe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
